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Abstract—Chronic fatigue syndrome (CFS) is characterized by severe fatigue, lasting for at least 6 months, 
for which no somatic explanation can he found. Because hyperventilation can produce substantial fa­
tigue, it seems worthwhile to investigate the relationship between it and CFS. It might be hypothesized 
that hyperventilation plays a causal or perpetuating role in CFS. CFS patients, non-CFS patients known 
to experience hyperventilation, and healthy controls were compared on complaints of fatigue and hyper­
ventilation. CFS patients and non-CFS patients known to experience hyperventilation offered substan­
tial complaints of fatigue and hyperventilation, both to a similar degree. Physiological evidence of hyper­
ventilation was found significantly more often in CFS patients than in healthy controls. However, no 
significant differences between CFS patients with and CFS patients without hyperventilation were found 
on severity of fatigue, impairment, number of complaints, activity level, psychopathology, and depres­
sion. It is concluded that hyperventilation in CFS should probably be regarded as an epiphenome- 
non. © 1997 Elsevier Science Inc.
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IN T R O D U C T IO N
Chronic  fatigue syndrome (CFS) is defined as severe fatigue, lasting for at least 6 
months,  for which no somatic explanation can be offered. The pathogenesis  of CFS 
is still unknown [ 1 ]. Because hyperventi lation can produce substantial fatigue, and 
because fatigue is one of the main complaints in hyperventilation, it seems w or th ­
while to investigate their relationship. Grossman and de Swart [2] showed that  64% 
of the patients with hyperventilat ion syndrome complained of tiredness. In add i­
tion, the fatigue in hyperventi lat ion [3] as well as in CFS [4-6] seems to be of a cen­
tral type.
One  might hypothesize that CFS is caused by hyperventilation. It is possible that 
stress causes hyperventilat ion,  which in turn might lead to chronic fatigue. A no the r  
possibility is that  hyperventi lation plays a perpetuat ing  role in CFS. Patients with
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CFS might develop hyperventi lation due to their fatigue, and hyperventi lation 
might in turn lead to an aggravation of fatigue.
Only a few studies have dealt with the relat ionship between CFS and hypervent i ­
lation. Rosen et al. [7] dem onst ra ted  hyperventi lation in 38 of 40 patients suffering 
from CFS and claimed that hyperventilation plays an important  role in the p a th o ­
genesis. Riley et al. [4], however,  found no differences in the mean end-tidal Pco2 
both before and after exercise between 13 patients  with CFS and 13 healthy con­
trols. Saisch et al. [8] found evidence for hyperventi lation in 9% of 31 CFS patients 
(29%). They did not find a relat ionship between the severity of hyperventi lat ion 
and the degree of functional impairment ,  which was to be expected when hyperven­
tilation would play a perpetuat ing  role in CFS.
The first purpose of the present  study is to de termine  whether  there is any evi­
dence for subjective complaints  of hyperventi lat ion in CFS, and whether  there is ev­
idence of fatigue in patients with hyperventi lat ion.  CFS patients and patients with 
known hyperventi lation are compared  to healthy controls to see whether  these 
complaints  are not only common but also specific for CFS and hyperventilat ion. 
The aim of the second part  of the study is to determine whether  there is any physio­
logical evidence for hyperventi lat ion in CFS and whether  CFS patients show physi­
ological evidence for hyperventi lation more frequently than healthy controls. In the 
third part  of the study, CFS patients with physiological evidence for hyperventi la­
tion (CFS HV) are com pared  to CFS patients without hyperventi lation (CFS non- 
HV ) on severity of fatigue, impairment,  num ber  of complaints,  activity level, psy­
chopathology. and depression, to de termine  the role of hyperventi lation in CFS.
M E T H O D
Sub jec ts
For the first part of this study, 39 patients with CFS and 32 healthy controls (all from a sample de­
scribed elsewhere) (9), completed the questionnaires. The healthy controls were matched and recruited 
by a regional newspaper advertisement. Furthermore, 17 non-CFS patients with established hyperventi­
lation (non-CFS HV) participated, all from the out-patient clinic of the Department of Pulmonology, 
Dekkerswald, University of Nijmegen. For the second and third parts of the study 27 CFS patients and 
the 32 healthy controls from the first part of ’he study participated. The experimental groups are not of 
an equal size because this study was linked to an already ongoing study.
All CFS patients were diagnosed at the General Internal Medicine out-patient clinic of the University 
Hospital. Nijmegen. CFS is defined as severe fatigue, lasting for at least 6 months, for which no somatic 
explanation can be offered. Patients were diagnosed with CFS if they fulfilled the Sharpe criteria [10]. 
According to these criteria, patients with a current diagnosis of major depression with melancholic or 
psychotic features, bipolar affective disorder, schizophrenia of any subtype, delusional disorders of any 
subtype, manic depressive illness, substance abuse, eating disorder, or proven organic brain disease (de­
mentias of any subtype) were excluded.
Patients and healthy controls were diagnosed as having hyperventilation when they fulfilled three of 
the following criteria [ 1 1 ]:
• Low Paco2 in rest (<4.5 kPa).
• High breathing frequency, irregular breathing, or frequent sighing in rest.
• Decreasing Paco2 in control condition on a spirometer.
• Inverted ventilatory response to co2.
• Adding co2 results in a regulation of breathing.
• One of the following criteria during or after the provocation test:
no step change in Petco2 when stopping voluntary hyperventilation;
no step change in respiratory frequency when stopping voluntary hyperventilation;
Paco2 3 minutes after the end of the provocation <90%  of the starting level.
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In s tru m e n ts
Subjective fatigue  was measured with the subscale of subjective fatigue of the Checklist of Individual 
Strength (CIS) [12]. On this scale, the minimum score is 1 and the maximum score is 7.
Level o f  impairment was assessed with the Sickness Impact Profile (SIP) [13]. This questionnaire mea­
sures the influence of complaints in different areas of daily functioning. For this study, eight subscales 
were used (alertness behavior, sleep, homemaking, leisure activities, work, mobility, social interac­
tions, ambulation).
Level o f  physical activity was assessed using an actometer. This apparatus is worn around the ankle 
for 2 weeks, recording the amount of movements every 5 minutes. This information is stored to an inter­
nal memory, and can be read by use of a personal computer [14].
Subjective complaints o f  hyperventilation were assessed by the Nijmegen Hyperventilation Question­
naire (NH Q ) [15]. The cutoff score for hyperventilation is 23.
Psychopathology  was measured with the Symptom Checklist (SCL-90R), an indicator of psychological 
disturbances, and the Beck Depression Inventory (BDI) [16, 17], a standardized self-report question­
naire for measuring depression.
Respiratory measurements were performed using a hyperventilation test in which the patient was con­
nected to a closed spirometer circuit by a mouthpiece. A sampling capnograph measured Pco2 in the re­
spiratory air. Resting respiratory parameters were measured during 5 minutes: minute ventilation, 
Pe tro :, breathing frequency, irregularity of breathing, and the time course of Petco2 during the first 5 
minutes of the test. Next, some co ; was given in the inspiratory air, to raise Pctco2 by 1.0±0.2 kPa. The 
response of the ventilation to the increase in Petco2 was measured during another 5 minutes. Subse­
quently, the patient was disconnected from the spirometer, and only Petco2 was monitored during a 
1-minute period of voluntary hyperventilation, and during the 3 minutes thereafter. The patients were 
asked whether they recognized their daily symptoms, during the hyperventilation. Finally, an arterialized 
capillary blood gas sample was taken to assess a possible metabolic acidosis, compensating for 
chronic hyperventilation.
S  tutistica l a nu  Iy  ses
The analysis of differences between groups on dichotomous variables was carried out with the chi- 
square test. Bonferroni correction was applied for the comparison of three experimental groups. Assum­
ing a significance level of 0.05, a difference was considered significant if the p<0.017. The analysis of dif­
ferences between two groups on ratio variables was carried out with the /-test, with the significance level 
set at p —0.05. The analysis of differences between more than two groups on ratio variables was per­
formed bv analysis of variance. Multiple comparisons were made bv Duncan’s multiple range tests, 
with /;<0.05.
R E S U L T S
First part
The mean age of the CFS patients was 36.5 ( s d =8.8), of the non-CFS patients 
with known hyperventi lation (non-CFS HV) 44.0 ( s d = 12.6 ), and of the healthy 
controls 37.0 ( s d = 12.8 ). Only the non-CFS HV patients differed significantly in age 
from the o ther  two groups. There  were no significant differences in gender:  80% of 
the CFS patients were female, as were 59% of the non-CFS HV patients and 84% 
of the healthy controls.
Data  concerning subjective complaints  of hyperventi lation and subjective com ­
plaints of fatigue are presented in Table I. On the N H Q ,  59% of the CFS patients 
scored above the cutoff  score for hyperventilation. This is significantly different 
from healthy controls (3%),  but not from non-CFS HV patients (65%). Non-CFS 
HV patients had a mean CIS score for subjective fatigue of 5.2. This is significantly 
different from healthy controls (2.0), but not from CFS patients (5.9).
Second part
The CFS patients and the healthy controls who underwent  respiratory m easure ­
ments did not differ significantly on age and gender.  Mean age of the CFS patients
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Table  I.— M ean scores ( s d )  on subjective com plain ts  of  hyperventila tion  
(N H Q ).  percen t above the cu toff  score for hyperventila tion  (N H Q  >  
23), and m ean  score ( s d ) of subjective fatigue (CIS) of 39 CFS patien ts  
com pared  to 17 non-C FS patien ts  with known hyperventila tion  (non-C FS
H V ) and 32 healthy contro ls
CFS N on-C FS  H V H ealthy
NHQ° 25.1 31.4 (11.6) 10.4 (6.3)
N H Q %  >  23b 59% 65 % 3%
CIS subjective fatigue0 5.9 (1.1) 5.2 (2.2) 2.0 ( 1 . 1 )
a O ne-w ay A N O V A  with D uncan  m ultip le-range test ( p  <  0.05), CFS sig­
nificantly different from non-CFS HV, and healthy controls, and non-CFS HV 
significantly different from healthy  controls.
hp  <  0.001; CFS significantly d ifferent from healthy contro ls  (p  <  0.001), 
and non-CFS HV significantly different from healthy controls (p  <  0.001); non- 
CFS HV is not significantly different from CFS.
ml
c O ne-w ay A N O V A , with D uncan multiple range test (/? <  0.05), CFS 
significantly different from healthy controls, non-C FS H V  significantly different 
from healthy controls; non-CFS H V  is not significantly different from CFS.
was 36.6 ( s d  = 8.0 ), and of the healthy controls 37.0 ( s d = 12.8). Seventy-eight p e r ­
cent of the CFS patients  were female,  compared  to 85% of the healthy controls. B e­
tween CFS patients and healthy controls significant differences were found on fa­
tigue, impairment ,  n u m b er  of complaints,  level of activity, subjective complaints  of 
hyperventi lation,  and psychopathology, as expected [9] (Table II).
Table  III shows the results of the respiratory m easurements  in CFS and healthy 
controls. Significantly more CFS patients showed hyperventi lation (59%) than did 
healthy controls (22%). CFS patients differed from healthy controls on Pe tco : and 
recognition of complaints,  but not on the o ther  respiratory parameters .
Third part
The 16 CFS patients  with hyperventi lation (CFS HV) and the 11 CFS patients 
without hyperventi lation (CFS non-H V ) were compared  on subjective fatigue 
(CIS),  impairment  (SIP), num ber  of complaints,  activity level (ac tometer) ,  subjec­
tive complaints specific for hyperventi lation (N H Q  score), psychopathology (SCL- 
90) and depression (BDI).  No significant differences between groups were found
T able  II.— M ean scores ( s d ) of 27 CFS patien ts  and 32 healthy controls 
recru ited  for resp ira to ry  m easurem ents ,  on subjective fatigue (CIS), 
im pairm en t (SIP), n u m b er  of com plaints , activity level (ac tom eter) ,  
subjective com plain ts  of  hyperventila tion  (N H Q ),  psychopathology
(SCL-90), and depression (B D I)
CFS H ealthy /?-valuea
CIS subjective fatigue 5.9 (1.0) 2.0 ( 1 . 1 ) <  0.001
SIP 17.1 (6.3) 1.2 (0.3) <  0.001
N u m be r o f co m plaints 7.4 (3.7) 0 (0.0 ) <  0.001
A c to m e te r 25.1 (12.3) 36.4 (12.2) <  0.001
N H Q 25.6 (11.3) 10.4 (25.6) <  0.001
SCL-90 155.4 (27.2) 106.9 (22.0) <  0.001
BDI 10.6 (5.3) 2.7 (4.0) <  0.001
a Using the t-test.
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Table  III.— M ean scores ( s d ) or percen tage  on resp ira tory  m easu rem en ts
in 27 CFS patien ts  and 32 healthy controls
CFS H ealthy p-V alue
P e tco2 (k P a );1 4.5 (0.66) 4.9 (0.40) <  0.005
P e tco2 <  4.5b 52% 22% <  0.05
P aco 2a 4.75 (0.69) 4.83 (0.57) NS
B reath ing  frequency” 13.1 (3.7) 15.1 (3.7) NS
Tidal volume 0.604 (0.20) 0.560 (0.18) NS
D ecreasing  P e tco2 36% 22% NS
Irregular b rea th ing '1 30% 16% NS
D elayed  recovery after
P rovocation '1 56% 38% NS
R ecognition '1
N one 41% 81% <  0.01
Partly 37% 13% <  0.01
C om plete ly 22% 6% <  0.01
H yperven tila tion , according 59% 22% <  0.005
to  physiological criteria*1
a Using the /-test. 
h Using the chi-square  test.
(Table IV). CFS HV patients as well as CFS non-H V  patients were both extremely 
fatigued and impaired. There  was neither a significant difference in the num ber  of 
complaints,  nor  the level of activity or subjective complaints of hyperventilation. Fi­
nally, CFS-FIV patients  and CFS non-H V  patients did not differ on psychopathol­
ogy and depression.
D IS C U S S IO N
Patients with CFS endorsed  subjective complaints of hyperventi lat ion,  similar to 
non-CFS patients with known hyperventilation. The latter showed substantial fa­
tigue, of similar severity as CFS patients. Physiological evidence for hyperventi la­
tion was found significantly more often in CFS patients (59%) than in healthy con­
trols (22%),  with a significant difference in the mean resting Pe tco2. Rosen et al. [7] 
found hyperventi lat ion in 93% of the CFS patients and 55% of the healthy controls.
T ab le  IV.— M ean scores ( s d ) of 16 CFS patien ts  with hyperventilation (CFS 
H V ) and  11 CFS patien ts  w ithout hyperventila tion  (CFS non-H V ) on 
subjective fatigue (CIS), im pairm en t (SIP), n u m b er  of com plaints , activity 
level (ac tom eter) ,  subjective com plaints  of hyperventila tion  (N H Q ),
psychopathology (SCL-90), and depression (B D I)
CFS HV CFS non-H V p - V  a lue ;‘
CIS subjective fatigue 5.8 (1.0) 6.0 (0.9) NS
SIP score 18.2 (6. 1 ) 16.4 (6.5) NS
N u m b er  of com plain ts 8.1 (3.6) 6.5 (3.7) NS
A cto m e te r 24.1 (10.2) 26.6 (15.2) NS
N H Q 25.6 (8.2) 25.5 (15.4) NS
SCL-90 153.9 (28.1) 157.9 (27.1) NS
BDI 10.1 (4.0) 11.4 (6.9) NS
a Using the t-test.
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whereas  Saisch et al. [8] found evidence for hyperventi lat ion in 29% of the CFS p a ­
tients, and Riley et al. [4] found no differences in the mean  Pe tco2 between CFS p a ­
tients and healthy controls. These conflicting findings can be explained by the differ­
ences in the criteria used in diagnosing hyperventilation.  In the study by Rosen et 
al. [7], less stringent criteria were used. Patients were also diagnosed with hyperven­
tilation if they had a positive “ think test": 3 minutes  after the hyperventi lat ion p rov­
ocation test, patients were requested  to close their eyes and think about  the c ircum­
stances of an attack and the feelings and sensations experienced. A fall of end-tidal 
Paco2 of 1.3 kPa or more  was taken as a positive response [18]. However,  the resting 
Pe tco2 in that study did not differ between CFS patients and healthy controls, as in 
the study of Riley et al. [4]. In the study by Saisch et al. [8], the criteria were more 
strict than in our  study. Patients were diagnosed with hyperventi lation only if the 
Pe tco2 was less than 4.0 kPa at rest, during or after exercise, or  at 5 minutes after 
the end of voluntary overbreathing.  Using the criterion of a Pe tco2 of less than 4.0 
kPa, in our  study, 19% of the CFS patients and none of the healthy controls were 
diagnosed with hyperventi lat ion.  This is closer to the finding of 29% hyperventi la t­
ing CFS patients found in the study by Saisch et al. [8].
If hyperventi lat ion plays an importan t  role in the pathogenesis  or perpetua t ion  of 
CFS, one would assume that hyperventi lation is com m on in CFS, and one would ex­
pect higher scores of fatigue and impairment  in the CFS patients with hyperventi la­
tion, compared  to the CFS patients  without hyperventilat ion. Like Saisch et al. [8], 
we found physiological evidence for hyperventi lat ion in some of the CFS patients, 
the exact percentage depending  on the criteria used. In addition, we could show that 
the high percentage of 93% found in the study by Rosen et al. [7] could be explained 
by the less strict criteria used: hyperventi lat ion in CFS is not as com m on as they sug­
gest. Compar ing  CFS patients with hyperventi lation to CFS patients without hyper­
ventilation, no differences on fatigue and impairment  were found, as in the study 
by Saisch et al. [8]. There  were also no differences found on variables such as the 
num ber  of complaints,  level of activity, psychopathology, and depression. If hyper­
ventilation plays a role in CFS, one would at least expect some differences. Using 
the strict criteria of a 4.0 kPa Paco2 at rest, five of our  CFS patients showed hyper­
ventilation. However,  even then, no differences are found between CFS patients 
with and CFS patients without hyperventilation. Therefore ,  it is unlikely that hyper­
ventilation plays a role in the pathogenesis  or perpe tua t ion  of CFS.
Depending on the criteria one uses, it can be said that signs of hyperventilation were 
found in a substantial number  of the CFS patients. Furthermore,  non-CFS HV pa­
tients had significantly more complaints of fatigue than healthy controls. However,  we 
did not find more complaints of fatigue in hyperventilating CFS patients than in non- 
hvperventilating CFS patients. Therefore,  hyperventilation is probably an epiphe- 
nomenon in CFS, and does not play a substantial causal or perpetuating role.
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